These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31257968)

  • 41. [Positron emission-computed tomography in diagnosis and staging of lung neoplasms. Personal experience].
    Mezzetti M; Calati AM; Schubert L
    Minerva Chir; 2002 Aug; 57(4):461-5. PubMed ID: 12145576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early lung cancer: screening and detection.
    Read C; Janes S; George J; Spiro S
    Prim Care Respir J; 2006 Dec; 15(6):332-6. PubMed ID: 17088104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [What's new in lung cancer].
    Letonturier P
    Presse Med; 2007 Mar; 36(3 Pt 1):441-3. PubMed ID: 17436450
    [No Abstract]   [Full Text] [Related]  

  • 44. Synchronous intrapulmonary schwannoma and primary lung cancer.
    Lococo F; Carlinfante G; Rapicetta C; Ricchetti T; Brandi L; Paci M; Carbonelli C; Sgarbi G
    Lung; 2015 Jun; 193(3):439-41. PubMed ID: 25773608
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent progress in positron emission tomography concerning diagnosis and treatment of lung cancer.
    Nakamura H
    Ann Thorac Cardiovasc Surg; 2012; 18(2):85-8. PubMed ID: 22523107
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinicopathological characteristics of screen-detected lung cancers.
    Kawachi R; Watanabe S; Asamura H
    J Thorac Oncol; 2009 May; 4(5):615-9. PubMed ID: 19318993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lung cancer: screening, staging, targeted therapies.
    Taffaro-Neskey M
    JAAPA; 2011 Dec; 24(12):65, 70. PubMed ID: 22315919
    [No Abstract]   [Full Text] [Related]  

  • 48. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
    Lopes Pegna A; Picozzi G; Falaschi F; Carrozzi L; Falchini M; Carozzi FM; Pistelli F; Comin C; Deliperi A; Grazzini M; Innocenti F; Maddau C; Vella A; Vaggelli L; Paci E; Mascalchi M;
    J Thorac Oncol; 2013 Jul; 8(7):866-75. PubMed ID: 23612465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer, concepts, cohorts and complexity: avoiding oversimplification of overdiagnosis.
    Detterbeck FC
    Thorax; 2012 Sep; 67(9):842-5. PubMed ID: 22628119
    [No Abstract]   [Full Text] [Related]  

  • 50. Lung cancer.
    Ginsberg MS; Grewal RK; Heelan RT
    Radiol Clin North Am; 2007 Jan; 45(1):21-43. PubMed ID: 17157622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative staging of lung cancer with combined PET-CT.
    Fischer B; Lassen U; Mortensen J; Larsen S; Loft A; Bertelsen A; Ravn J; Clementsen P; Høgholm A; Larsen K; Rasmussen T; Keiding S; Dirksen A; Gerke O; Skov B; Steffensen I; Hansen H; Vilmann P; Jacobsen G; Backer V; Maltbaek N; Pedersen J; Madsen H; Nielsen H; Højgaard L
    N Engl J Med; 2009 Jul; 361(1):32-9. PubMed ID: 19571281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study.
    Veronesi G; Maisonneuve P; Bellomi M; Rampinelli C; Durli I; Bertolotti R; Spaggiari L
    Ann Intern Med; 2012 Dec; 157(11):776-84. PubMed ID: 23208167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Guidelines for the early diagnosis of lung cancer for primary care physicians].
    Vestn Rentgenol Radiol; 2016; 97(2):69-78. PubMed ID: 27522701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Updates in small cell lung cancer treatment.
    Walker S
    Clin J Oncol Nurs; 2003; 7(5):563-8. PubMed ID: 14603554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significance of
    Kim E; Wu HG; Keam B; Kim TM; Kim DW; Paeng JC; Kim HJ; Chang JH
    Clin Lung Cancer; 2019 Jan; 20(1):e9-e23. PubMed ID: 30266585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis: Early warning system.
    Bourzac K
    Nature; 2014 Sep; 513(7517):S4-6. PubMed ID: 25208071
    [No Abstract]   [Full Text] [Related]  

  • 57. What should be the routine follow-up after definitive therapy of localized lung cancer?
    Pieters RS; Krutchik AN; Kane GC; Friedland DM
    Semin Oncol; 1996 Aug; 23(4):xv-xxvii, comment xxvii-xxviii. PubMed ID: 8928024
    [No Abstract]   [Full Text] [Related]  

  • 58. Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers.
    Pastorino U; Landoni C; Marchianò A; Calabrò E; Sozzi G; Miceli R; Picchio M; Mariani L; Messa C; Fazio F
    J Thorac Oncol; 2009 Nov; 4(11):1352-6. PubMed ID: 19861905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Contribution of PET/CT for staging and prognosis of non-small cell lung carcinoma. Assessment of the pathological response].
    Kerrou K
    Rev Pneumol Clin; 2009 Feb; 65(1):49-55. PubMed ID: 19306785
    [No Abstract]   [Full Text] [Related]  

  • 60. PET/CT for staging and monitoring non small cell lung cancer.
    Rankin S
    Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S27-31. PubMed ID: 18852078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.